This text is a result of machine translation.
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
HeyTea Bets on Coffee, Again
Coffee is a darling among Chinese youth.
Jun 22, 2022 10:25 PM
Can Nayuki Hold Its Ground in the Evermore Competitive On-demand Tea Drinks Industry
Nayuki is one of the largest firms in China’s sprawling on-demand tea drinks industry. Financial indicators such as revenue and operating margins have proved its success in the past. But the ultimate question is, how long can it last?
Jun 07, 2022 11:02 AM
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
Yingsi intelligence and Fosun Pharmaceutical reached the first milestone of strategic cooperation: nomination and targeting cd47-sirp α Small molecule compounds of signal pathway
How Can Solar Companies Seize Opportunities in the Post-Subsidy Era?
Oct 10, 2024 05:23 PM
Mexicans Who Can’t Afford Tacos Flock to Chinese Restaurants
Oct 08, 2024 11:11 AM